Dermal wound healing
Thymosin β-4 applied topically/systemically to standardized wound model.
Accelerated re-epithelialization, contraction, and angiogenesis vs. vehicle.

Synthetic Thymosin Beta-4 fragment for repair research.
TB-500 is a synthetic version of the active region of Thymosin β-4 used in soft-tissue research.
Binds G-actin, promoting cell migration and angiogenesis in in-vitro repair models.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Thymosin β-4 applied topically/systemically to standardized wound model.
Accelerated re-epithelialization, contraction, and angiogenesis vs. vehicle.
Quantified follicle stem-cell recruitment under Tβ4 administration.
Increased hair growth via documented stem-cell activation pathway.
Tβ4 in post-MI cardiac repair, integrin-linked kinase signaling.
Improved cardiomyocyte survival, migration, and functional recovery.
Lyophilized -20°C.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — TB-500 is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.